# Evaluation of Factors II, VII, IX, X, and Proteins C and S, Following High-dose Vitamin K Supplementation

> **NCT01143831** · NA · COMPLETED · sponsor: **Stephan Moll, MD** · enrollment: 8 (actual)

## Conditions studied

- Thrombosis

## Interventions

- **DIETARY_SUPPLEMENT:** Vitamin K, 20mg

## Key facts

- **NCT ID:** NCT01143831
- **Lead sponsor:** Stephan Moll, MD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2012-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01143831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01143831, "Evaluation of Factors II, VII, IX, X, and Proteins C and S, Following High-dose Vitamin K Supplementation". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT01143831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*